| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.5805 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.6443 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.6624 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.6752 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.6817 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.6826 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.6838 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.7015 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.7224 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.7449 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.7461 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.7469 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.7791 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.7797 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.7884 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.7989 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8137 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8160 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8273 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8303 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8346 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8395 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8407 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8434 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8438 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8465 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8536 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8577 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8641 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8669 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8693 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8744 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8799 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8848 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8911 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8911 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8916 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8941 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.8995 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9016 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9100 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9155 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9183 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9205 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9269 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9546 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9684 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9686 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9692 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9713 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9771 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9774 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9780 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9792 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9815 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9843 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9910 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9926 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9934 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9940 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9948 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9968 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9973 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 0.9985 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0000 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0010 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0048 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0084 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0087 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0087 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0129 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0131 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0174 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0216 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0234 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0246 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0259 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0329 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0356 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0443 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0477 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0491 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0530 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0531 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0538 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0546 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0762 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0764 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0777 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0818 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0858 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0913 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0920 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0949 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0965 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.0993 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1157 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1168 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1174 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1203 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1322 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1351 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1478 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1607 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1613 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1737 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1744 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.1868 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2010 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2029 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2096 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2104 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2269 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2315 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2407 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2691 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2718 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2784 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.2897 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.3034 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.3054 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.3106 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.3243 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.3302 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.3315 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.3840 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.4255 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.4523 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.4654 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 5-oxoproline | 1.5604 | Peak area | Lean |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|